The stock of this Pharma Company Hits 20 per cent Upper Circuit with High Intraday Volumes; FIIs Increased their Stake in Q2 FY25 The stock of this Pharma Company Hits 20 per cent Upper Circuit with High Intraday Volumes; FIIs Increased their Stake in Q2 FY25 The stock has given returns of 36 per cent returns in the last 6 months. Prajwal Wakhare / Tuesday, December 3, 2024 / Article rating: 4.5
This Pharma Company Reports 25 per cent Profit Growth: Aiming for Rs 750 Crore Revenue by FY26, Promoter and FIIs Increased their Stake This Pharma Company Reports 25 per cent Profit Growth: Aiming for Rs 750 Crore Revenue by FY26, Promoter and FIIs Increased their Stake The company has given returns of 46.23 per cent in a year. Prajwal Wakhare / Thursday, August 8, 2024 / Article rating: 3.8